Our Company

Good Therapeutics is a discovery-stage biotechnology company based in Seattle, WA, with $22 million in Series A funding from Codon Capital, Roche Venture Fund, Rivervest Venture Partners, Digitalis Ventures and 3x5 Partners.

Our Team
Leadership
JOHN MULLIGAN, PhD Bio Picture
Founder and CEO
DIANE HOLLENBAUGH, PhD Bio Picture
Head of Research
JUSTIN KILLEBREW, PhD Bio Picture
Director of Immuno-Oncology Discovery
Board of Directors
JOHN MULLIGAN, PhD Bio Picture
Founder and CEO
KARL HANDELSMAN Bio Picture
Founder & Managing Partner, Codon Capital
JOHN MCKEARN, PhD Bio Picture
Managing Director, Rivervest
MONIQUE SCHIERSING, MSc MBA Bio Picture
Senior Investment Director, Roche Venture Fund
NICHOLAS WALROD Bio Picture
Managing Director & co-founder, 3x5 Partners
Board Observer
SAM BJORK Bio Picture
Principal at Digitalis

Join Us

Good Therapeutics is led by a team of energetic and experienced scientists, business leaders, and creative minds